Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Clinical Trial ID NCT00004067

PubWeight™ 67.09^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00004067

Top papers